Novavax's stock was trading down more than 6% Tuesday afternoon after the company lowered its guidance for sales for the year ...

The partnership also allows Sanofi to use the company's adjuvant, Matrix-M ... One-trick pony? The Novavax logo displayed on ...

The global artificial intelligence (AI) in drug discovery market is projected to reach USD 6.89 billion by 2029 from USD 1.86 ...

A treatment of acute myeloid leukemia being developed by Sanofi (SNY) US Services was granted FDA orphan designation, according to a post to the agency’s website. Published first on TheFly – the ...

Zucara Therapeutics Inc., ("Zucara" or the "Company") a diabetes life sciences company developing ZT-01, the first once-daily therapeutic to prevent hypoglycemia (low blood glucose levels) in people ...

Brad Lightcap, COO, OpenAI "We believe AI can accelerate drug development, bringing new treatments to patients more quickly. This first product from our collaboration with Sanofi and Formation Bio is ...

The company at the start of the year said it expected to make as much as $1 billion in revenue. Jacobs acknowledged that ...

Yuichi Iwaki, M.D., Ph.D., MediciNova CEO commented, “The successful resolution of the Sanofi-Novartis litigation and the resulting monetary damages due to MediciNova both validates the value of our ...

In a statement to Windows Central, Microsoft has confirmed that it's unifying its news content services under the MSN brand once again.

NEW YORK, Nov. 7, 2024 /PRNewswire/ -- Fortune announced today additional confirmed speakers for the 2024 Fortune Global Forum , the premier gathering of CEOs and leaders of the world's largest ...

Biotech company Illumina last year said it would divest diagnostic test maker Grail after heated battles with the FTC and ...